{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-003445","form_type":"8-K","ticker":"MTNB","cik":"0001582554","company_name":"Matinas BioPharma Holdings, Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.531231+00:00","generated_at":"2026-05-16T08:24:23.002026+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Matinas BioPharma CFO Keith Kucinski resigns; CEO Jerome Jabbour named interim CFO","bullets":["Keith Kucinski resigned as CFO effective January 17, 2026, to pursue other opportunities.","Board appointed CEO and Chairman Jerome D. Jabbour as interim CFO effective January 22, 2026.","Jabbour retains roles as Chairman, President, and CEO; assumes principal financial and accounting officer duties.","No change in Jabbour's compensation or other material terms in connection with appointment.","No family relationships or transactions between Jabbour and any director or officer requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-003445","json":"https://secwatch.observer/filing/0001493152-26-003445.json","markdown":"https://secwatch.observer/filing/0001493152-26-003445.md","text":"https://secwatch.observer/filing/0001493152-26-003445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582554/000149315226003445/0001493152-26-003445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582554/000149315226003445/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:24:23.002026+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}